Human Embryonic Stem Cell Line (OD)

ICR 201907-0925-003

OMB: 0925-0601

Federal Form Document

Forms and Documents
IC Document Collections
IC ID
Document
Title
Status
190155 Modified
ICR Details
0925-0601 201907-0925-003
Active 201605-0925-003
HHS/NIH 19378
Human Embryonic Stem Cell Line (OD)
Extension without change of a currently approved collection   No
Regular
Approved with change 10/10/2019
Retrieve Notice of Action (NOA) 07/24/2019
  Inventory as of this Action Requested Previously Approved
10/31/2022 36 Months From Approved 10/31/2019
15 0 150
255 0 2,550
0 0 0

This is an extension of 0925-0601, Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research. Executive Order (EO) 13505 states that NIH may support and conduct responsible, scientifically worthy human stem cell research, including human embryonic stem cell (hESC) research. The NIH Guidelines for Human Stem Cell Research (Guidelines), implementing the EO, established an NIH Registry of eligible hESC lines that comply with the set of standards described in the Guidelines. The Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research will continue to be used by respondents who have hESC lines and wish for the lines to be approved for use in NIH funded research.

EO: EO 13505 Name/Subject of EO: Removing Barriers to Responsible Scientific Research Involving Human Stem Cells
  
None

Not associated with rulemaking

  84 FR 22153 05/16/2019
84 FR 35401 07/23/2019
No

1
IC Title Form No. Form Name
Form 2890-Stem Cell 1 Form 2890

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 15 150 0 -135 0 0
Annual Time Burden (Hours) 255 2,550 0 -2,295 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
Yes
Miscellaneous Actions
This an extension even though the number of responses have been reduced substantially. Program indicates that through Form 2890, NIH receives information from institutions about human embryonic stem cell lines that they have derived. NIH then determines whether the embryo donation consent process meets the strict requirements in NIH policy for use of the cell lines by NIH-funded investigators. NIH does not fund the derivation of the cell lines and has no involvement in the decisions that institutions make regarding derivation of new cell lines. In recent years, there have been fewer submissions to NIH about newly derived cell lines.

$26,117
No
    Yes
    Yes
No
No
No
Uncollected
Mikia Currie 3014350941

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
07/24/2019


© 2024 OMB.report | Privacy Policy